Skip to main content
KANGSTEM BIOTECH CO., LTD. logo

KANGSTEM BIOTECH CO., LTD. — Investor Relations & Filings

Ticker · 217730 ISIN · KR7217730001 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2020-03-30 Audit Report / Informat…
Country KR South Korea
Listing KO 217730

About KANGSTEM BIOTECH CO., LTD.

https://kangstem.com

KANGSTEM BIOTECH CO., LTD. is a biopharmaceutical company that researches and develops advanced stem cell therapies. The company focuses on creating treatments for rare, incurable, and autoimmune diseases, with a pipeline that includes therapeutic candidates for neurological disorders. Leveraging proprietary technologies for the isolation and mass culture of mesenchymal stem cells, Kangstem Biotech also develops and commercializes stem cell culture media and related cosmetic products. The company is dedicated to addressing unmet medical needs through the development of next-generation biopharmaceuticals.

Recent filings

Filing Released Lang Actions
사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Kangstem Biotech' (주식회사 강스템바이오텍) for the fiscal year ending December 31, 2019. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes. While it contains financial data, it is specifically the formal audit report issued by an accounting firm (Anjin Accounting Corp), which falls under the 'Audit Report' category rather than a general Annual Report (10-K) or Interim Report (IR). FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the voting outcomes for various agenda items, including financial statement approval, director appointments, and remuneration limits. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Kangstem Biotech. It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the fiscal year. While it contains financial data, it is a standard regulatory disclosure announcement required by the KRX (Korea Exchange) when an audit report is finalized and submitted, rather than the full, multi-page annual report document itself. Therefore, it fits the 'Report Publication Announcement' category. FY 2019
2020-03-17 Korean
기타경영사항(특허권취득)(자율공시)(HMGA2를 이용하여 비신경 세포로부터 리프로그래밍 된)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure ('자율공시') regarding the acquisition of a patent ('특허권 취득') by Kangstem Biotech. It details the patent name, content, and utilization plan. Since this is a specific corporate announcement regarding a business development (patent acquisition) that does not fit into financial reporting, M&A, or governance categories, it falls under the general regulatory filing category.
2020-03-17 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Kangstem Biotech. It contains the agenda for the meeting, including the approval of financial statements, election of directors, and remuneration limits. It also includes management's discussion of business operations and financial data (management reports/proxy information). This type of document is standard for providing shareholders with the necessary information to vote at an AGM, fitting the definition of Proxy Solicitation & Information Statement (PSI).
2020-03-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (including directors and relatives). This type of filing is specifically used to notify the market of significant changes in shareholding levels (crossing thresholds or changes in major ownership), which corresponds to the 'Major Shareholding Notification' category.
2020-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.